(Q38842323)

6 September 2017

title

A7RC peptide modified paclitaxel liposomes dually target breast cancer (English)

1 reference

6 September 2017

1 reference

Jingyan Cao

1

1 reference

6 September 2017

Ran Wang

2

1 reference

6 September 2017

Ning Gao

3

1 reference

6 September 2017

Minghui Li

4

1 reference

6 September 2017

Xuyu Tian

5

1 reference

6 September 2017

Weili Yang

6

1 reference

6 September 2017

Ying Ruan

7

1 reference

6 September 2017

Chunlan Zhou

8

1 reference

6 September 2017

Guangtian Wang

9

1 reference

6 September 2017

Xiaoying Liu

10

1 reference

6 September 2017

Shukun Tang

11

1 reference

6 September 2017

Yan Yu

12

1 reference

6 September 2017

Ying Liu

13

1 reference

6 September 2017

Guangyu Sun

14

1 reference

6 September 2017

Haisheng Peng

15

1 reference

6 September 2017

Qun Wang

16

1 reference

6 September 2017

publication date

20 August 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

3

1 reference

6 September 2017

issue

12

1 reference

6 September 2017

page(s)

1545-1554

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

6 September 2017

1 reference

Paclitaxel: a review of adverse toxicities and novel delivery strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

How do anti-mitotic drugs kill cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Hypersensitivity reactions from taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Recent developments in taxane drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Liposomes modified with P-aminophenyl-α-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Functional nanoparticles in targeting glioma diagnosis and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Advances in self-assembled chitosan nanomaterials for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Liposomal encapsulated anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Liposomes: versatile and biocompatible nanovesicles for efficient biomolecules delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Preparation and characterization of taxane-containing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Paclitaxel drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Liposomal paclitaxel formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Neuropilin is a semaphorin III receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Neuropilins in physiological and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Neuropilins in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Targeting endothelial and tumor cells with semaphorins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Tissue-penetrating delivery of compounds and nanoparticles into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Liposomes modified with p-aminophenyl-α-D-mannopyranoside: a promising delivery system in targeting the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Probing the relevance of 3D cancer models in nanomedicine research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Liposomal drug formulations in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Neuropilins: expression and roles in the epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

NRP-1 expression in bladder cancer and its implications for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

Heart-targeted nanoscale drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5BM00161G

21 January 2018

Identifiers

DOI

10.1039/C5BM00161G

1 reference

6 September 2017

1 reference